What happened with the FDA and compounded GLP-1s, and who is still operating legally?

Short version

• The FDA has moved to stop many pharmacies from making compounded copies of GLP‑1 drugs (semaglutide, tirzepatide, etc.). FDA says compounding exact copies of approved GLP‑1 products or compounding from bulk GLP‑1 active pharmaceutical ingredients (APIs) is generally not legal or supported because those bulk APIs aren’t on the FDA’s approved “bulk drug substance” list and copies of approved drugs are “unapproved new drugs.”
• As a result, a number of compounding shops paused or were warned; many clinics stopped offering compounded GLP‑1s. That left legally available options being (a) FDA‑approved brand products prescribed and dispensed through normal channels, (b) certain state‑licensed 503A pharmacies that compound only patient‑specific prescriptions and comply with state/federal rules, and (c) registered 503B outsourcing facilities that follow FDA requirements (though 503B facilities are limited in making copies of approved products).

What the FDA specifically did

• Issued public statements and enforcement actions (warning letters/inspections) targeting pharmacies and facilities compounding GLP‑1s from bulk APIs or making unapproved copies of approved drugs. The FDA’s legal position: compounding an unapproved copy of an FDA‑approved product or compounding from unlisted bulk APIs isn’t generally permitted unless there’s a valid medical need or shortage and the pharmacy meets applicable statutes/regulations.
• The agency has not added semaglutide/tirzepatide bulk substances to any FDA “bulk list,” which made compounding from raw GLP‑1 API particularly vulnerable to enforcement.

Who is still operating legally

• FDA‑approved manufacturers and their products (fully legal): examples you can get via prescription and a pharmacy
  • Novo Nordisk: Ozempic (semaglutide, diabetes), Wegovy (semaglutide, obesity/weight-loss indication), Rybelsus (oral semaglutide)
  • Eli Lilly: Mounjaro (tirzepatide, diabetes), Zepbound (tirzepatide — approved for weight management as of 2024) These are the safest, FDA‑approved options — prescribed by clinicians and dispensed by regular pharmacies or specialty pharmacies.
• 503A compounding pharmacies: may still legally compound GLP‑1s only when they meet state pharmacy laws and federal limits (generally patient‑specific prescriptions). If they’re compounding a drug that is essentially a copy of an FDA‑approved product or using bulk API that isn’t allowed, that can trigger FDA action. Many 503A pharmacies stopped compounding GLP‑1s because of the enforcement risk.
• 503B outsourcing facilities: must be registered with FDA and comply with current good manufacturing practice (cGMP); they can produce larger batches but face strict limits about making copies of approved drugs and using non‑approved bulk APIs.
• Telehealth/medical clinics that prescribe and use FDA‑approved GLP‑1 drugs: many telemedicine providers (for example, PlushCare, Ro/Roman, Hims & Hers, GoodRx Care and similar established platforms) will evaluate you and prescribe an FDA‑approved GLP‑1 when appropriate. Those are legal when prescriptions are issued by licensed clinicians.

How to verify legality for a specific provider or pharmacy

• Check the FDA warning letters and enforcement notices (FDA.gov) for named pharmacies.
• Ask the pharmacy/clinic directly:
  • Are you compounding from bulk API or dispensing an FDA‑approved product? (If bulk API, ask for the Certificate of Analysis and the API source.)
  • Are you a 503A state‑licensed compounding pharmacy or a 503B outsourcing facility? Are you registered with the FDA?
  • Can you provide proof of state pharmacy licensure and inspections?
• Check your state board of pharmacy website for disciplinary actions or guidance.

Practical recommendation

• If you need a GLP‑1 for diabetes or weight management, the safest path is to get evaluated and, when appropriate, prescribed one of the FDA‑approved products (Wegovy, Ozempic, Rybelsus, Mounjaro, Zepbound). Use an established pharmacy or telehealth clinic that dispenses or fills the branded/generic FDA‑approved products.
• Only consider compounded GLP‑1s if you have a documented medical reason (allergy to an ingredient, special formulation need) and you confirm the compounding pharmacy is operating within state and federal rules (and is transparent about sourcing and testing).

If you want, tell me a specific pharmacy or clinic you’re asking about and I’ll help you check for public enforcement actions and suggest next steps.